Company: DMAC
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001437749-25-009696
Chunk: 11

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 11
---
—ELECTION OF DIRECTORS</div>

Board Size and Structure

Our Articles provide that the Board of Directors will consist of at least three members. The size of the Board of Directors is currently fixed at eight since the Board of Directors currently consists of eight directors. The Board of Directors has reduced the size of the Board at seven effective as of the Annual General Meeting since Richard Pilnik, a current director, is not standing for re-election at the Annual General Meeting.

Each director is elected annually by the shareholders and serves for a term that will end at the next annual general meeting of shareholders.

Information about Board Nominees

The Board of Directors has nominated the following seven individuals to serve as our directors until the next annual general meeting of shareholders or until their respective successors are elected and qualified. All of the nominees for director named below are current members of the Board of Directors.

| Name                                | Age | Position                                        |
| James Parsons(1)(2)                 |  59 | Chairman of the Board                           |
| Rick Pauls                          |  53 | President and Chief Executive Officer, Director |
| Michael Giuffre, M.D.(1)(3)(4)(5)   |  69 | Director                                        |
| Richard Kuntz, M.D., M.Sc.(1)(2)(5) |  67 | Director                                        |
| Tanya Lewis(1)(3)(4)(5)             |  54 | Director                                        |
| Daniel O’Connor(1)(2)(4)            |  60 | Director                                        |
| Charles Semba, M.D.(1)(2)(3)(5)     |  65 | Director                                        |

| (1) | Independent Director |

| (2) | Member of the Audit Committee |

| (3) | Member of the Compensation Committee |

| (4) | Member of the Nominating and Corporate Governance Committee |

| (5) | Member of the Scientific and Clinical Research Committee |

Richard Pilnik, a current Board member and the former Chairman of the Board, is not standing for re-election at the Annual General Meeting. The Board of Directors thanks Mr. Pilnik for his 16 years of dedicated service to our Company, including during the last 10 years serving as Chairman of the Board.

Additional Information about Board Nominees

The following paragraphs provide information about each current director and nominee for director, including all positions held, principal occupation and business experience for the past five years, and the names of other publicly-held companies